The 2020 AMA physician survey revealed that employed physicians surpassed the 50% mark for the first time. And that same survey reported a 12.5% drop since 2012 in the percent of physicians in small group practice.  Why does NextGen Advisor, Dr. Marty Lustick, believe we’ll see a resurgence of small practices in the U.S.? Listen to the podcast to find out more.

The NextGen Advisors take us on a scientific roller coaster ride of discovery, failure, innovation and medical triumph in the search for COVID vaccines and treatments.

The new year represents a significant transition for the NextGen Advisors with Dr. Betty’s retirement. Listen here for Dr. Betty Rabinowitz’s reflections on a career well spent and the Advisors predictions for 2022.

The Affordable Care Act reaffirmed the centrality of primary care as the foundation supporting the entire American health care system. In today’s podcast, the NextGen Advisors discuss a report written in collaboration between the Robert Graham Center, the American Board of Family Medicine, and IBM Watson Health titled, "Primary care in the United States a Chartbook of Facts and Statistics". The Advisors provide their views on this interesting, updated snapshot of the state of primary care in the United States.

Every October, several advocacy and research organizations focus their efforts on building awareness and engagement with the public regarding diseases and conditions which have a large impact on our population. In this episode, NextGen® Advisors Graham Brown and Dr. Betty Rabinowitz discuss national breast cancer awareness month and national depression and mental health screening month, as well as developments at the FDA regarding booster shots for COVID-19.

In this podcast, the NextGen® Advisors discuss the role of Health Information Technology (HIT) in supporting patient engagement. Recently, NextGen Healthcare commissioned Xtelligent Healthcare Media to conduct a survey of leaders of ambulatory care provider organizations on this subject. Listen to this episode to hear the Advisors reflect on the survey results and discuss priorities for advancing patient engagement.

Recently, the U.S. passed a grim milestone with deaths of Americans from COVID-19 surpassing American deaths from the Spanish flu, the deadly influenza pandemic that spanned about 2 years from 1918.  In today’s podcast, the NextGen Advisors reflect on this milestone and the impact that vaccines have had on the course of the pandemic.  The conversation sheds light on the underlying reasons for vaccine hesitancy and the special consideration for pediatric vaccines.

Lack of adherence to a treatment regimen is estimated to cause approximately 125,000 annual deaths and cost the U.S. healthcare system between $100-289 billion per year. In this episode of the NextGen® Advisors podcast, we explore the many factors associated with non-adherence as well as strategies providers may consider to address this challenge.

Alzheimer’s disease affects 6.2 million Americans each year so the recent approval by the FDA of Biogen’s drug Aduhelm was met with hope by many patients and their advocates. The approval process used by the FDA, the efficacy data compiled to date, and the expected annual cost of the drug have created a swirl of controversy around the decision.  In this episode of the NextGen Advisors podcast, Graham Brown and Dr. Betty Rabinowitz discuss the drug’s approval and the concerns, hopes and implications it has raised.

In this episode, the NextGen® Advisors explore the unique characteristics of the SARS-COV2 Delta variant and the reasons that it is posing a challenge to health officials across the world.